GlaxoSmithKline Archives -

News/ News/ News/ Patients/ Sales and Marketing

GSK, Sanofi and Haleon ‘facing billions of dollars in Zantac liability’

Phil Taylor GlaxoSmithKline, Haleon, litigation, Pfizer, safety, Sanofi, Zantac 0 Comment

GSK, its consumer health spin-off Haleon, and Sanofi could be on the hook for billions of dollars in

GSK, Sanofi and Haleon ‘facing billions of dollars in Zantac liability’

https://pharmaphorum.com/news/gsk-sanofi-and-haleon-facing-billions-of-dollars-in-zantac-liability/

News/ News/ R&D

Chinese biotech Sironax raises $200m for RIPK1 pipeline

Phil Taylor China, Eli Lilly, financing, Genfleet Therapeutics, GlaxoSmithKline, Immunology and inflammation, Rigel Pharmaceuticals, RIPK1, Sanofi, Sironax 0 Comment

Beijing biotech Sironax has closed a whopping $200 million second-round financing that shows investors still have a desire

Chinese biotech Sironax raises $200m for RIPK1 pipeline

https://pharmaphorum.com/news/chinese-biotech-sironax-raises-200m-for-ripk1-pipeline/

News/ News/ Sales and Marketing

Record Shingrix sales help GSK raise 2022 forecasts

Phil Taylor Financial, GlaxoSmithKline, Haleon, HIV, respiratory syncytial virus, Shingrix, vaccine, ViiV Healthcare 0 Comment

In its first set of financial figures since spinning off its consumer health division, GSK has reported a

Record Shingrix sales help GSK raise 2022 forecasts

https://pharmaphorum.com/news/record-shingrix-sales-help-gsk-raise-2022-forecasts/

News/ News/ R&D

Ex-GSK vaccine chief to lead new UK biotech Vicebio

Phil Taylor GlaxoSmithKline, respiratory syncytial virus, vaccines, Vicebio 0 Comment

GSK’s former head of vaccines R&D – Dr Emmanuel Hanon – is heading up a new biotech called

Ex-GSK vaccine chief to lead new UK biotech Vicebio

https://pharmaphorum.com/news/ex-gsk-vaccine-chief-to-lead-new-uk-biotech-vicebio/

News/ News/ Sales and Marketing

GSK consumer health spin-off Haleon starts trading

Phil Taylor consumer health, Financial, GlaxoSmithKline, Haleon, Pfizer 0 Comment

GSK’s consumer health spinout Haleon started trading on the London Stock Exchange this morning, making its debut with

GSK consumer health spin-off Haleon starts trading

https://pharmaphorum.com/news/gsk-consumer-health-spin-off-haleon-starts-trading/

Supreme Court columns with American flag and US Capitol

News/ News/ Sales and Marketing

Teva asks SCOTUS to overturn “skinny label” verdict on GSK drug

Phil Taylor generic, GlaxoSmithKline, patent litigation, SCOTUS, Teva 0 Comment

Teva has asked the Supreme Court to look at a judgment in a $235 million patent dispute with

Teva asks SCOTUS to overturn “skinny label” verdict on GSK drug

https://pharmaphorum.com/news/teva-asks-scotus-to-overturn-skinny-label-verdict-on-gsk-drug/

News/ News/ R&D

Partners come on board GSK’s plan for Stevenage life science hub

Phil Taylor cluster, GlaxoSmithKline, Life Sciences, UK 0 Comment

GSK’s recently-unveiled plan to develop a bioscience cluster close to its main R&D site in Stevenage, UK, has

Partners come on board GSK’s plan for Stevenage life science hub

https://pharmaphorum.com/news/partners-come-on-board-gsks-plan-for-stevenage-life-science-hub/

News/ News/ Sales and Marketing

Pfizer seeks to overturn three RSV vaccine patents held by GSK

Phil Taylor GlaxoSmithKline, patent litigation, Pfizer, respiratory syncytial virus, vaccine 0 Comment

Already competing to bring the first vaccine against respiratory syncytial virus (RSV) to market, Pfizer and GSK are

Pfizer seeks to overturn three RSV vaccine patents held by GSK

https://pharmaphorum.com/news/pfizer-seeks-to-overturn-three-rsv-vaccine-patents-held-by-gsk/

Market Access/ News/ News/ News/ R&D

US panel backs Omicron-targeting vaccines for booster campaigns

Phil Taylor BioNTech, coronavirus, COVID-19, COVID-19 vaccine, fda, GlaxoSmithKline, Moderna, Novavax, Omicron, Pfizer, regulatory, variant 0 Comment

Future booster campaigns against COVID-19 should include vaccines with a component targeting the Omicron variant of SARS-CoV-2, according

US panel backs Omicron-targeting vaccines for booster campaigns

https://pharmaphorum.com/news/us-panel-backs-omicron-targeting-vaccines-for-booster-campaigns/

Trending

GlaxoSmithKline

Login